CG
SIOX

Cutler Group’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Cutler Group’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,000
Closed -$5K – 6532
2020
Q4 		$5K Buy
+2,000
New +$5.82K ﹤0.01% 3724
2020
Q1 		– Sell
-7,500
Closed -$38K – 4870
2019
Q4 		$38K Buy
+7,500
New +$41.6K ﹤0.01% 1823
2019
Q2 		– Sell
-1,300
Closed -$13K – 4969
2019
Q1 		$13K Hold
1,300
– – ﹤0.01% 2350
2018
Q4 		$10K Hold
1,300
– – ﹤0.01% 2557
2018
Q3 		$25K Sell
1,300
-213
-14% -$3.88K ﹤0.01% 2108
2018
Q2 		$27K Sell
1,513
-1,037
-41% -$15.3K ﹤0.01% 1994
2018
Q1 		$27K Buy
2,550
+812
+47% +$13K ﹤0.01% 2080
2017
Q4 		$73K Sell
1,738
-4,884
-74% -$219K ﹤0.01% 1595
2017
Q3 		$364K Buy
6,622
+3,869
+141% +$653K 0.01% 821
2017
Q2 		$510K Buy
2,753
+1,056
+62% +$185K 0.02% 684
2017
Q1 		$202K Sell
1,697
-2,123
-56% -$223K 0.01% 1186
2016
Q4 		$379K Buy
3,820
+3,209
+525% +$338K 0.01% 865
2016
Q3 		$68K Buy
611
+361
+144% +$43.3K ﹤0.01% 2164
2016
Q2 		$25K Sell
250
-1,344
-84% -$134K ﹤0.01% 3128
2016
Q1 		$146K Buy
1,594
+1,278
+404% +$136K 0.01% 1259
2015
Q4 		$45K Buy
+316
New +$41.1K ﹤0.01% 2590

Other funds holding SIOX

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TVWM
Tower View Wealth Management Shorewood, Wisconsin $195M AUM 29.88% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Cutler Group's SIOX Position: Q1 2021 in Review

Cutler Group sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2021, closing a stake of 2,000 shares — an estimated $5K sold.

Cutler Group first reported a position in SIOX in Q4 2015 and held it in 16 quarters. The position peaked at $510K in Q2 2017. 56 funds tracked by Wall St. Rank hold SIOX as of Q1 2021.

  • Cutler Group reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Cutler Group sold 2,000 Sio Gene Therapies Inc. Common Stock shares in Q1 2021, an estimated $5K.
  • Cutler Group first reported a position in Sio Gene Therapies Inc. Common Stock in Q4 2015 and held it in 16 quarters.
  • Cutler Group's Sio Gene Therapies Inc. Common Stock position peaked at $510K in Q2 2017.
  • 56 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2021.

Based on Cutler Group's 13F filing for Q1 2021, filed 26 Apr 2021.